How does aspirin affect the stomach lining, and why?
Aspirin damages the stomach lining mainly because it blocks COX enzymes that produce prostaglandins in the gut. Those prostaglandins normally help protect the stomach by maintaining the mucus/bicarbonate barrier and supporting blood flow to the lining. When aspirin reduces these protective prostaglandins, the stomach becomes more vulnerable to irritation and ulcers. This stomach risk is a well-known feature of “non-selective” COX inhibition.
What do COX-2 inhibitors do differently in the stomach?
COX-2 inhibitors are designed to block the COX-2 pathway more selectively. Since COX-1–derived prostaglandins are relatively less affected, COX-2 inhibitors tend to cause less disruption of the normal stomach protective mechanisms than non-selective COX inhibitors like aspirin. In practice, that generally means lower risk of upper gastrointestinal (GI) irritation and ulceration compared with drugs that strongly block both COX-1 and COX-2.
Why the difference happens mechanistically
The key distinction is which COX products are reduced:
- Aspirin (non-selective COX inhibition) reduces prostaglandins involved in protecting the stomach lining.
- COX-2 inhibitors primarily reduce inflammatory prostaglandins tied to COX-2 activity, leaving more of the COX-1–mediated protective functions intact.
Are COX-2 inhibitors completely “stomach safe”?
No. COX-2 inhibitors can still affect the GI tract, just typically less than non-selective options like aspirin. The remaining risk depends on dose and individual factors (history of ulcers, age, and other medications such as steroids or anticoagulants).
What this means for someone choosing between them
If stomach irritation or ulcer risk is the main concern, COX-2 inhibitors are often considered less likely to cause GI bleeding or ulcers than aspirin. Aspirin may still be used for specific reasons (for example, cardiovascular prevention), but that usually comes with strategies to protect the stomach (such as using the lowest effective dose and considering gastroprotective therapy).
Sources
No sources were provided with your question, and I can’t cite from memory here. If you share the reference material you want me to use (or allow web lookup), I can answer with exact sourcing.